LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2

被引:62
作者
Han, Shuhua [1 ]
Cao, Dandan [1 ]
Sha, Jun [1 ]
Zhu, Xiaoli [1 ]
Chen, Dongqin [2 ,3 ,4 ]
机构
[1] Southeast Univ, Sch Med, Zhongda Hosp, Dept Pulm Med, Ding Jia Qiao 87, Nanjing 210009, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Affiliated Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China
[3] Jiangsu Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China
[4] Jiangsu Inst Canc Res, Nanjing 210009, Jiangsu, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
lung adenocarcinoma; mRNA decay; UPF1; ZFPM2; ZFPM2-AS1; LONG NONCODING RNA; SURVEILLANCE FACTOR UPF1; CANCER; CELL; EXPRESSION; COFACTOR; GROWTH; DECAY; FOG-2;
D O I
10.1002/1878-0261.12631
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung adenocarcinoma (LUAD), a histological subclass of non-small-cell lung cancer, is globally the leading cause of cancer-related deaths. Long noncoding RNAs (lncRNAs) are emerging as cancer regulators. Zinc finger protein multitype 2 antisense RNA 1 (ZFPM2-AS1) is an oncogene in gastric cancer, but its functions have not been investigated in LUAD. We showed that ZFPM2-AS1 expression is high in LUAD samples based on GEPIA database () and validated ZFPM2-AS1 upregulation in LUAD cell lines. Functionally, ZFPM2-AS1 facilitated proliferation, invasion, and epithelial-to-mesenchymal transition of LUAD cells. Thereafter, we found that ZFPM2 was negatively regulated by ZFPM2-AS1, and identified the suppressive effect of ZFPM2 regulation by ZFPM2-AS1 on LUAD progression. Mechanistically, we showed that ZFPM2-AS1 interacted with up-frameshift 1 (UPF1) to regulate mRNA decay of ZFPM2. Rescue assays in vitro and in vivo confirmed that ZFPM2-AS1 regulated LUAD progression and tumor growth through ZFPM2. Taken together, our findings demonstrate a role for the ZFPM2-AS1-UPF1-ZFPM2 axis in LUAD progression, suggesting ZFPM2-AS1 as a new potential target for LUAD treatment.
引用
收藏
页码:1074 / 1088
页数:15
相关论文
共 32 条
[1]   The human RNA surveillance factor UPF1 is required for S phase progression and genome stability [J].
Azzalin, CM ;
Lingner, J .
CURRENT BIOLOGY, 2006, 16 (04) :433-439
[2]   lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3′ UTRs via Alu elements [J].
Gong, Chenguang ;
Maquat, Lynne E. .
NATURE, 2011, 470 (7333) :284-+
[3]   A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA [J].
He, Jia ;
Zuo, Qiaozhu ;
Hu, Bo ;
Jin, Haojie ;
Wang, Cun ;
Cheng, Zhuoan ;
Deng, Xuan ;
Yang, Chen ;
Ruan, Haoyu ;
Yu, Chengtao ;
Zhao, Fangyu ;
Yao, Ming ;
Fang, Jingyuan ;
Gu, Jianren ;
Zhou, Jian ;
Fan, Jia ;
Qin, Wenxin ;
Yang, Xin-Rong ;
Wang, Hui .
CANCER LETTERS, 2019, 450 :98-109
[4]   Molecular origins of cancer: Lung cancer [J].
Herbst, Roy S. ;
Heymach, John V. ;
Lippman, Scott M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) :1367-1380
[5]   GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes [J].
Hoene, V. ;
Fischer, M. ;
Ivanova, A. ;
Wallach, T. ;
Berthold, F. ;
Dame, C. .
BRITISH JOURNAL OF CANCER, 2009, 101 (08) :1481-1489
[6]   HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling [J].
Hu, Jiao-Jiao ;
Song, Wei ;
Zhang, Shao-Dan ;
Shen, Xiao-Hui ;
Qiu, Xue-Mei ;
Wu, Hua-Zhang ;
Gong, Pi-Hai ;
Lu, Sen ;
Zhao, Zhu-Jiang ;
He, Ming-Liang ;
Fan, Hong .
SCIENTIFIC REPORTS, 2016, 6
[7]   Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression [J].
Huang, B. ;
Song, J. H. ;
Cheng, Y. ;
Abraham, J. M. ;
Ibrahim, S. ;
Sun, Z. ;
Ke, X. ;
Meltzer, S. J. .
ONCOGENE, 2016, 35 (37) :4927-4936
[8]   Conserved MicroRNA miR-8/miR-200 and Its Target USH/FOG2 Control Growth by Regulating PI3K [J].
Hyun, Seogang ;
Lee, Jung Hyun ;
Jin, Hua ;
Nam, JinWu ;
Namkoong, Bumjin ;
Lee, Gina ;
Chung, Jongkyeong ;
Kim, V. Narry .
CELL, 2009, 139 (06) :1096-1108
[9]   LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis [J].
Jiang, Liangfeng ;
Wu, Zhiming ;
Meng, Xingcheng ;
Chu, Xiufeng ;
Huang, Hongjun ;
Xu, Chaoyang .
HUMAN GENE THERAPY, 2019, 30 (05) :618-631
[10]  
Kim MH, 2015, INT J CLIN EXP PATHO, V8, P15933